• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lyra Therapeutics Inc (NQ: LYRA )

    0.2303 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 939
    Open 0.2303
    Bid (Size) 0.2311 (2)
    Ask (Size) 0.2425 (6)
    Prev. Close 0.2303
    Today's Range 0.2303 - 0.2303
    52wk Range 0.2303 - 6.790
    Shares Outstanding 31,836,815
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    LYRA Stock Earnings: Lyra Therapeutics Beats EPS, Beats Revenue for Q2 2024
    LYRA stock results show that Lyra Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Lyra Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
    Via Benzinga

    Performance

    YTD
    -95.57%
    -95.57%
    1 Month
    -23.11%
    -23.11%
    3 Month
    -15.33%
    -15.33%
    6 Month
    -95.64%
    -95.64%
    1 Year
    -93.94%
    -93.94%

    More News

    Read More
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Where Lyra Therapeutics Stands With Analysts
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    What 4 Analyst Ratings Have To Say About Lyra Therapeutics
    Via Benzinga
    Lyra Therapeutics: Q1 Earnings Insights
    Via Benzinga
    Lyra Therapeutics's Return On Capital Employed Insights
    Via Benzinga
    Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 Results
    Via Benzinga
    Exposures Fossil Fuels
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    DJT Stock: Trump Media Fires Accounting Firm, Hires Replacement After SEC Charges
    Via InvestorPlace
    Topics Government Regulatory Compliance
    Exposures Legal Political Regulatory
    ZK Stock IPO: When Does Zeekr Go Public? What Is the Zeekr IPO Price Range?
    Via InvestorPlace
    Topics Initial Public Offering
    Exposures Securities Market
    Nasdaq Jumps 100 Points; Tyson Foods Sales Miss Views
    Via Benzinga
    Topics Earnings
    Exposures Financial
    Warren Buffett Just Gave Up on Paramount (PARA) Stock
    Via InvestorPlace
    Why Is Lyra Therapeutics (LYRA) Stock Down 90% Today?
    Via InvestorPlace
    Why Lyra Therapeutics Stock Is Down 93% Today
    Via Benzinga
    LYRA Stock Earnings: Lyra Therapeutics Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    LYRA Stock Earnings: Lyra Therapeutics Beats EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.